Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.
about
Oxytocin receptor antagonists for inhibiting preterm labourOxytocin receptor antagonists for inhibiting preterm labourAtosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.The pathophysiology of pulmonary oedema with the use of beta-agonists.Management of preterm labor: atosiban or nifedipine?Tocolytic therapy for preterm delivery: systematic review and network meta-analysisA Gly/Ala switch contributes to high affinity binding of benzoxazinone-based non-peptide oxytocin receptor antagonists.Development and clinical experience with the new evidence-based tocolytic atosiban.An update on the controversies of tocolytic therapy for the prevention of preterm birth.The development and introduction of anti-oxytocic tocolytics.Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents.A quality assessment tool to evaluate tocolytic studies.The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.Developments in the pharmacotherapeutic management of spontaneous preterm labor.Regulation of uterine smooth muscle function during gestation.Therapy side-effects and predictive factors for preterm delivery in patients undergoing tocolysis with atosiban or ritodrine for threatened preterm labour.Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes.Design of oxytocin antagonists, which are more selective than atosiban.Pharmacokinetic interaction studies of atosiban with labetalol or betamethasone in healthy female volunteers.Oxytocin is not important for the control of gonadotrophin secretion in the late follicular phase of the cycle.The functional role of oxytocin in the induction of oocyte meiotic resumption in cattle.
P2860
Q24194079-4D2C400E-CCB7-4CA7-BD1A-E9CD3016C996Q24246646-E17C2727-F9A5-4C1C-898E-CBBC7BD25E16Q33470751-DA351740-C36C-4335-A8F3-EA4AF7E50BD3Q33888110-BA330906-3F94-4D69-B465-36C2536959A6Q34272127-DF2D60F9-42CB-46FF-B600-FFD0A9B1C7ADQ34304826-F6162011-47F4-4541-8A8D-4C6E78D1F708Q34383214-F61A9104-682A-4A9F-A520-AAE9FCE3C87DQ34792360-09F59588-35A5-448C-B01F-FD702F36A805Q35064290-D3BFCA5C-8EF6-488A-B711-B4D336D4190DQ35134341-AAB3B7DD-EC9D-4006-9595-9FB64DDAD6B4Q35603917-F673DA8E-D88F-4532-A114-9C396C47C2B9Q35606442-83ECF269-2C8E-46D3-ABB3-344A2D7A25EEQ36700889-E3952388-6B55-4ED0-A2A1-28D26F07B3AAQ36821366-0E96C596-B7A7-425C-A325-4B3577DB1A2FQ37142064-A8E27B29-A542-43F4-8D68-3DF9E9D76426Q38549143-18129BE5-BD64-49D1-A21A-EDF0F52A4BB2Q40202592-511EE253-7E77-46B8-87A2-61E60835C38EQ42005700-6DCE31EA-55C9-4DFC-9E37-4DD48CF271D1Q43756689-C6E94C4B-1AEA-4F24-AC85-ADCB9DDB41F9Q46753271-27DAB2CA-BD6D-46A1-9369-2C64DA13B873Q48218008-0520EF02-B5EB-4485-8625-A3F3DA2922FAQ48624564-3D0AAC8A-70FD-4A13-92C6-C4508359D203
P2860
Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Dose ranging study of the oxyt ...... m labor. Atosiban Study Group.
@en
Dose ranging study of the oxyt ...... m labor. Atosiban Study Group.
@nl
type
label
Dose ranging study of the oxyt ...... m labor. Atosiban Study Group.
@en
Dose ranging study of the oxyt ...... m labor. Atosiban Study Group.
@nl
prefLabel
Dose ranging study of the oxyt ...... m labor. Atosiban Study Group.
@en
Dose ranging study of the oxyt ...... m labor. Atosiban Study Group.
@nl
P2093
P1476
Dose ranging study of the oxyt ...... rm labor. Atosiban Study Group
@en
P2093
G J Valenzuela
T M Goodwin
P304
P356
10.1016/0029-7844(96)00200-1
P407
P577
1996-09-01T00:00:00Z